Highlights
NASDAQ: ENDP       Endo Int'l Plc
Last Price Today's Change   Day's Range   Trading Volume
5.79   +0.32 (5.85%)  5.50 - 5.845  4,317,800

Overview

 
Avg Volume (4 weeks):7,037,720
4 Weeks Range:2.88 - 6.09
4 Weeks Price Volatility (%):
90.65%
52 Weeks Range:2.08 - 7.10
52 Weeks Price Volatility (%):
73.90%
Average Price Target: 75.00
Price Target Upside/Downside: +69.21

Headlines



No recent Headlines for this stock.


Business Background

Endo International PLC, formerly Endo Health Solutions Inc., is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm , Opana ER, Voltaren Gel, Percocet , Frova , Supprelin LA, Vantas , Valstar and Fortesta Gel. The Company operates in three segments: Endo Pharmaceuticals, Qualitest and AMS. In April 2014, the Company acquired worldwide rights to Sumavel DosePro (sumatriptan injection) for subcutaneous use, a needle-free delivery system for sumatriptan, from Zogenix, Inc. In July 2014, it acquired Grupo Farmaceutico Somar. In August 2014, Endo International PLC acquired DAVA Pharmaceuticals, Inc., a privately-held company specializing in generic pharmaceuticals.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5351  3123  585  200 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EVK 2.60+1.43 
 SNAP 38.97+2.47 
 AAPL 115.75-1.12 
 GE 7.72+0.40 
 AAL 13.15+0.405 
 T 28.28+1.56 
 OAS 0.155-0.014 
 F 8.21+0.36 
 SQQQ 21.75-0.01 
 NIO 27.38-0.48